Literature DB >> 10329559

Functional complementation of the envelope hypervariable V3 loop of human immunodeficiency virus type 1 subtype B by the subtype E V3 loop.

H Sato1, K Kato, Y Takebe.   

Abstract

The hypervariable V3 loop within gp120 of human immunodeficiency virus type 1 (HIV-1) is the major determinant of cell tropism and the entry coreceptor usage of the virus. However, the information obtained thus far has been from only subtype B from North America and Europe, and little is known about other subtypes whose V3 amino acids differ by as much as 50% from subtype B V3. In this study, we examined the functional potential of the V3 element of the HIV-1 subtype E, the most crucial variant causing the AIDS epidemic throughout southeast Asia. A panel of HIV-1LAI recombinants was constructed by the overlap extension method, by which the LAI V3 loop was precisely replaced by that of the subtype E nonsyncytium-inducing (NSI) or syncytium-inducing (SI) variant. All of the recombinant viruses infected peripheral blood mononuclear cells, whereas only those with SI V3 infected MT2 cells, a CD4(+) T cell line. Consistently, the SI V3 recombinants used CXCR4, while the NSI V3 recombinants used CCR5 for infection of HOS-CD4(+) cells. Finally, only the NSI V3 sequence conferred CC-chemokine sensitivity on the parental virus. The data support the notion that the HIV-1 V3 loop consists of a relatively independent domain in gp120 and suggest that the subtype E V3 loop indeed contains the functional element to dictate the cell tropism, coreceptor preference, and chemokine sensitivity of the virus. These findings are of immediate importance in understanding V3 structure-function relationship and for examining phenotypic evolution of HIV-1 subtype E. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10329559     DOI: 10.1006/viro.1999.9670

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  10 in total

1.  Cognitive Function Among Antiretroviral Treatment-Naive Individuals Infected With Human Immunodeficiency Virus Type 1 Subtype G Versus CRF02_AG in Nigeria.

Authors:  Jibreel Jumare; Nicaise Ndembi; Samer S El-Kamary; Laurence Magder; Laura Hungerford; Tricia Burdo; Lindsay M Eyzaguirre; Patrick Dakum; Anya Umlauf; Mariana Cherner; Alash'le Abimiku; Man Charurat; William A Blattner; Walter Royal
Journal:  Clin Infect Dis       Date:  2018-04-17       Impact factor: 9.079

2.  A group of V3 sequences from human immunodeficiency virus type 1 subtype E non-syncytium-inducing, CCR5-using variants are resistant to positive selection pressure.

Authors:  T Shiino; K Kato; N Kodaka; T Miyakuni; Y Takebe; H Sato
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  Role of naturally occurring basic amino acid substitutions in the human immunodeficiency virus type 1 subtype E envelope V3 loop on viral coreceptor usage and cell tropism.

Authors:  K Kato; H Sato; Y Takebe
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

4.  Evolution and biological characterization of human immunodeficiency virus type 1 subtype E gp120 V3 sequences following horizontal and vertical virus transmission in a single family.

Authors:  H Sato; T Shiino; N Kodaka; K Taniguchi; Y Tomita; K Kato; T Miyakuni; Y Takebe
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

5.  Convergent evolution of reverse transcriptase (RT) genes of human immunodeficiency virus type 1 subtypes E and B following nucleoside analogue RT inhibitor therapies.

Authors:  H Sato; Y Tomita; K Shibamura; T Shiino; T Miyakuni; Y Takebe
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

6.  Engineered CD4- and CXCR4-using simian immunodeficiency virus from African green monkeys is neutralization sensitive and replicates in nonstimulated lymphocytes.

Authors:  Renate R König; Egbert Flory; Stefanie Steidl; Jeanette Neumann; Cheick Coulibaly; Edgar Holznagel; Silke Holzammer; Stephen Norley; Klaus Cichutek
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

7.  Structural dynamics of HIV-1 envelope Gp120 outer domain with V3 loop.

Authors:  Masaru Yokoyama; Satoshi Naganawa; Kazuhisa Yoshimura; Shuzo Matsushita; Hironori Sato
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

8.  Net positive charge of HIV-1 CRF01_AE V3 sequence regulates viral sensitivity to humoral immunity.

Authors:  Satoshi Naganawa; Masaru Yokoyama; Teiichiro Shiino; Takeyuki Suzuki; Yoshiaki Ishigatsubo; Atsuhisa Ueda; Akira Shirai; Mitsuhiro Takeno; Satoshi Hayakawa; Shigehiro Sato; Osamu Tochikubo; Shingo Kiyoura; Kaori Sawada; Takashi Ikegami; Tadahito Kanda; Katsuhiko Kitamura; Hironori Sato
Journal:  PLoS One       Date:  2008-09-12       Impact factor: 3.240

9.  Immunogenicity of a polyvalent HIV-1 candidate vaccine based on fourteen wild type gp120 proteins in golden hamsters.

Authors:  Ali Azizi; David E Anderson; Masoud Ghorbani; Katrina Gee; Francisco Diaz-Mitoma
Journal:  BMC Immunol       Date:  2006-10-31       Impact factor: 3.615

10.  Antigenic and 3D structural characterization of soluble X4 and hybrid X4-R5 HIV-1 Env trimers.

Authors:  Philipp Arnold; Patricia Himmels; Svenja Weiß; Tim-Michael Decker; Jürgen Markl; Volker Gatterdam; Robert Tampé; Patrick Bartholomäus; Ursula Dietrich; Ralf Dürr
Journal:  Retrovirology       Date:  2014-05-30       Impact factor: 4.602

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.